• Mashup Score: 0
    Paper: Patient-Centered Care in Hematology: How Side Effect Severity Influences Decision-Making Autonomy in Relapsed Refractory Multiple Myeloma - 3 month(s) ago

    Program: Oral and Poster Abstracts Type: Oral Session: 907. Outcomes Research: Plasma Cell Disorders: Frailty, Supportive Care, and Factors Impacting Outcomes Hematology Disease Topics & Pathways: Research, Adult, Elderly, Health outcomes research, Clinical Research, Plasma Cell Disorders, Health disparities research, Diseases, Patient-reported outcomes, Lymphoid Malignancies, Registries, Study Population, Human Jorge Arturo Hurtado Martinez, MD 1 *, Felipe Flores Quiroz, MD 1 *, Jennifer M. Ahlstrom, BA

    Source: ash.confex.com
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Patient-Centered Care in Hematology: How Side Effect Severity Influences Decision-Making Autonomy in Relapsed Refractory Multiple Myeloma [Dec 8, 2024] Martinez et al. #ASH27 Abst 706 https://t.co/l7SHPBwbna #mmsm HT @Taxkourel

  • Mashup Score: 3
    Webprogram Unavailable - 3 month(s) ago

    Please click HERE if you are not redirected in 5

    Source: ash.confex.com
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Role of TNFRSF17 and GPRC5D Structural and Point Mutations in Resistance to Targeted Immunotherapies in Multiple Myeloma (MM) [Dec 10, 2022] Lee et al. Abst 101 #ASH22 https://t.co/uFh0vyd5mx #mmsm #CARTcell #PrecisionMedicine

  • Mashup Score: 0
    Webprogram Unavailable - 3 month(s) ago

    Please click HERE if you are not redirected in 5

    Source: ash.confex.com
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Multiomics Profiling of Measurable Residual Disease (MRD) for Understanding the Biology of Ultra-Drug Resistance in Multiple Myeloma (MM) [Dec 10, 2022] @camilagdeblois et al. Abst 99 #ASH22 https://t.co/izMBdiswlP #mmsm #mmMRD https://t.co/Pqd9dhwohw

  • Mashup Score: 2
    Webprogram Unavailable - 3 month(s) ago

    Please click HERE if you are not redirected in 5

    Source: ash.confex.com
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Revealing the Impact of Recurrent and Rare Structural Variations in Multiple Myeloma - @EHRustad et al. #ASH19 Abstract 576 https://t.co/kchnpIPzfs #mmsm #cagenome https://t.co/KsZkuJAS8R

  • Mashup Score: 0
    Paper: Patient-Centered Care in Hematology: How Side Effect Severity Influences Decision-Making Autonomy in Relapsed Refractory Multiple Myeloma - 3 month(s) ago

    Program: Oral and Poster Abstracts Type: Oral Session: 907. Outcomes Research: Plasma Cell Disorders: Frailty, Supportive Care, and Factors Impacting Outcomes Hematology Disease Topics & Pathways: Research, Adult, Elderly, Health outcomes research, Clinical Research, Plasma Cell Disorders, Health disparities research, Diseases, Patient-reported outcomes, Lymphoid Malignancies, Registries, Study Population, Human Jorge Arturo Hurtado Martinez, MD 1 *, Felipe Flores Quiroz, MD 1 *, Jennifer M. Ahlstrom, BA

    Source: ash.confex.com
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Patient-Centered Care in Hematology: How Side Effect Severity Influences Decision-Making Autonomy in Relapsed Refractory Multiple Myeloma [Dec 8, 2024] Martinez et al. #ASH27 Abst 706 https://t.co/l7SHPBwbna #mmsm HT @Taxkourel

  • Mashup Score: 6
    Paper: The Early Benefits and Psychological Effects of Screening for Monoclonal Gammopathy of Undetermined Significance: Results of the Istopmm Study - 3 month(s) ago

    Program: Oral and Poster Abstracts Type: Oral Session: 654. MGUS, Amyloidosis and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Screening to Vaccines–The Spectrum of Plasma Cell Disorders Hematology Disease Topics & Pathways: Research, clinical trials, Clinical Research, Plasma Cell Disorders, patient-reported outcomes, Diseases, Lymphoid Malignancies, Human Sæmundur Rögnvaldsson, MD, PhD 1,2 *, Sigrun Thorsteinsdottir, MD, PhD 2,3, Jon Oskarsson, MSc 2 *, Elias Eythorsson, MD,

    Source: ash.confex.com
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of DrOlaLandgren
      DrOlaLandgren

      Dr Saemundur Rognvaldsson @SaemundurMD will present data on the early benefits and psychological effects of screening for monoclonal gammopathy of undetermined significance: results of the iStopMM study https://t.co/PcjvDO30R0 @sykristinsson #mmsm #ASH23

  • Mashup Score: 0
    Paper: Patient-Centered Care in Hematology: How Side Effect Severity Influences Decision-Making Autonomy in Relapsed Refractory Multiple Myeloma - 4 month(s) ago

    Program: Oral and Poster Abstracts Type: Oral Session: 907. Outcomes Research: Plasma Cell Disorders: Frailty, Supportive Care, and Factors Impacting Outcomes Hematology Disease Topics & Pathways: Research, Adult, Elderly, Health outcomes research, Clinical Research, Plasma Cell Disorders, Health disparities research, Diseases, Patient-reported outcomes, Lymphoid Malignancies, Registries, Study Population, Human Jorge Arturo Hurtado Martinez, MD 1 *, Felipe Flores Quiroz, MD 1 *, Jennifer M. Ahlstrom, BA

    Source: ash.confex.com
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Patient-Centered Care in Hematology: How Side Effect Severity Influences Decision-Making Autonomy in Relapsed Refractory Multiple Myeloma [Dec 8, 2024] Martinez et al. #ASH27 Abst 706 https://t.co/l7SHPBwbna #mmsm HT @Taxkourel

Load More